M A Dayton
Overview
Explore the profile of M A Dayton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li B, Khosravi M, Berkel H, Diamandi A, Dayton M, Smith M, et al.
Int J Cancer
. 2001 Mar;
91(5):736-9.
PMID: 11267989
Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein...
2.
Zheng J, Kulp S, Zhang Y, Sugimoto Y, Dayton M, Govindan M, et al.
Anticancer Res
. 2000 Apr;
20(1A):11-9.
PMID: 10769629
Background: Protein tyrosine phosphatase gamma (PTP gamma) has been implicated as a potential tumor suppressor gene in kidney and lung adenocarcinomas. We have previously shown that PTP gamma mRNA expression...
3.
Kim J, Dayton M, Aldrich W, Triozzi P
Cancer Immunol Immunother
. 1999 Dec;
48(9):525-32.
PMID: 10602890
Purpose: Mucins have been implicated in tumor-associated immunosuppression. The possibility that colon cancer mucin (CCM) may modulate T-helper 1 (TH1) activity was evaluated by investigating its effect on the production...
4.
Liang J, PROUTY L, Williams B, Dayton M, Blanchard K
Blood
. 1998 Sep;
92(6):2118-22.
PMID: 9731070
Chromosomal abnormalities in acute leukemia have led to the discovery of many genes involved in normal hematopoiesis and in malignant transformation. We have identified the fusion partners in an inv(8)(p11q13)...
5.
Walker M, Silliman E, Dayton M, Lang J
Anticancer Res
. 1998 Jun;
18(2A):1129-35.
PMID: 9615777
The rapidly increasing incidence of malignant melanoma and lack of effective systemic therapy for advanced disease has given rise to the need for new approaches. The suggestion that c-myb may...
6.
Dayton M, Knobloch T
Recept Signal Transduct
. 1997 Jan;
7(4):241-56.
PMID: 9633825
Protein tyrosine phosphatases are important components of signal transduction pathways. The authors have used reverse transcription/polymerase chain reactions to accomplish a comprehensive examination of the RNA expression for 58 distinct...
7.
Keane M, Lowrey G, Ettenberg S, Dayton M, Lipkowitz S
Cancer Res
. 1996 Sep;
56(18):4236-43.
PMID: 8797598
Sodium butyrate-induced differentiation of breast cancer cell lines was used to identify protein tyrosine phosphatases (PTPs) involved in differentiation and growth inhibition of breast cancer cells. Of 42 PTPs analyzed,...
8.
Triozzi P, Walker M, Pellegrini A, Dayton M
Cancer Invest
. 1996 Jan;
14(4):293-8.
PMID: 8689422
Twenty-five patients with metastatic malignant melanoma were treated with isotretinoin (13-cis-retinoic acid) orally at 1 mg/kg daily and recombinant interferon alfa-2a (INF-alpha) subcutaneously at 3 million units daily for 16-48...
9.
Benjamin D, Sharma V, Knobloch T, Armitage R, Dayton M, Goodwin R
J Immunol
. 1994 May;
152(10):4749-57.
PMID: 8176200
IL-7 was originally reported as a cytokine produced by stromal cells which supports pre-B cell proliferation in vitro. To determine whether human B cells secrete IL-7 and express IL-7R we...
10.
Dayton M, Knobloch T, Benjamin D
Cytokine
. 1992 Nov;
4(6):454-60.
PMID: 1292629
Interferon gamma (IFN-gamma) production has been attributed exclusively to activated T cells and NK cells. We sought to determine whether human B cells express IFN-gamma. We studied 28 B cell...